Skip to main content
Clinical Trials/PACTR202404890252448
PACTR202404890252448RecruitingUnknown

A pilot pre- post trial of the feasibility, acceptability, tolerability, and efficacy of accelerated bilateral theta-burst stimulation for depression in adults with HIV in South Africa

Faculty of Medicine and Health Sciences0 sites10 target enrollmentStarted: March 28, 2024Last updated:

Trial Snapshot

Phase
Unknown
Status
Recruiting
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 Year(s) to 44 Year(s) (—)
Sex
All

Inclusion Criteria

  • Adults (= 18 years) diagnosed with HIV
  • On ART for an uninterrupted period of at least six months
  • Current comorbid MDD diagnosis confirmed by a diagnostic interview.
  • Able to attend the treatment and monitoring visits at the university campus during office hours.
  • Able to provide written informed consent.
  • For participants on psychotropic medication, a stable dose (=2 months) will be required before the pre-treatment assessment. These participants will continue with their current treatment regimens for the duration of their trial participation.
  • Participants will also be required not to engage in other interventions (i.e., psychotherapy) during the study
  • period (six weeks from pre-treatment to one-month follow-up).

Exclusion Criteria

  • Known with life-threatening medical illnesses (e.g., cancer), or serious psychiatric conditions (e.g., psychosis, mania).
  • Participants with specific TMS-associated contraindications (e.g., metal implants close to the skull area or uncontrolled epilepsy) will also be excluded.

Investigators

Similar Trials